|
US2018050020A1
|
|
Ifetroban treatment of portal hypertension
|
|
CN109152767A
|
|
With the composition and method of thromboxane-A2 receptor antagonist treatment muscular dystrophy
|
|
AU2017258296A1
|
|
Ifetroban treatment for systemic sclerosis
|
|
CA2990880A1
|
|
Thromboxane receptor antagonists in aerd/asthma
|
|
CN106999454A
|
|
Intravenous brufen and paracetamol is co-administered to treat pain
|
|
EP3804717A1
|
|
Compositions and methods of treating systemic sclerosis or pulmonary arterial hypertension
|
|
AU2014277744A1
|
|
Stabilized Statin Formulations
|
|
EP2825039A2
|
|
Injectable ibuprofen formulation
|
|
AU2011281035A1
|
|
Acetycysteine compositions and methods of use thereof
|
|
AU2011202871A1
|
|
Acetylcysteine composition and uses therefor
|
|
AU2011240925A1
|
|
Stabilized statin formulations
|
|
AU2010224063A1
|
|
Administration of intravenous ibuprofen
|
|
CN102625656A
|
|
Treating critically ill patients with intravenous ibuprofen
|
|
WO2005065674A1
|
|
Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
|
|
US2003100612A1
|
|
Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
|
|
CA2462452A1
|
|
Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
|
